20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T40330 | Anticancer agent 15 | ||
Anticancer agent 15, an anticancer agent, exerts its efficacy by elevating intracellular levels of reactive oxygen species (ROS) and inducing cell death in melanoma cancer cells through necroptosis. | |||
T40479 | Anticancer agent 13 | ||
Anticancer agent 13 is an anticancer agent from dicarboxylic acids and amines. | |||
T39868 | Anticancer agent 11 | ||
Anticancer agent 11 an effective broad-spectrum anticancer agent, exerts its therapeutic potential by suppressing angiogenesis and facilitating the formation of DNA cross-links. | |||
T39501 | Anticancer agent 7 | ||
Anticancer agent 7 (Example 5) is an anti-cancer agent that exhibits potent anticancer activity against H1650 lung cancer cells, with an IC50 value of 5 μM. | |||
T10331 | Anticancer agent 3 | Others | |
Anticancer agent 3 (Compound 4) is a anti-cancer agent. | |||
T60420 | Anticancer agent 73 | DNA/RNA Synthesis | |
Anticancer agent 73 is an anticancer agent which potently targets transactivation response(TAR) RNA-binding protein 2 (TRBP) and disrupts the TRBP-Dicer interaction. Anticancer agent 73 suppresses the growth and metasta... | |||
T61046 | Anticancer agent 43 | Apoptosis | |
Anticancer agent 43 is a potent anticancer agent that induces apoptosis through caspase 3, PARP1, and Bax protein-dependent pathways.Anticancer agent 43 induces DNA damage and can be used in the study of glioblastoma in ... | |||
T60852 | Anticancer agent 46 | ||
Anticancer agent 46 is a potent anti-cancer agent, showing anti-proliferative activity in cellular assays, with an IC50 of 0.986 μM against MGC803 cells. | |||
T27998 | MDK-4204 | Anticancer AgentI,MDK 4204,Anticancer Agent I,MDK4204,Anticancer Agent-I | |
MDK-4204, an anticancer agent, shows significant anti-cancer activity with IC50 values of 8.8 µM and 9.5 µM in PC-3 and DU-145 cells, respectively. | |||
T62602 | Anticancer agent 49 | ||
Anticancer agent 49 (compound 69) is a broad-spectrum anticancer agent with anti-proliferative activity. anticancer agent 48 inhibits microtubule protein aggregation and has in vivo antitumour activity. anticancer agent ... | |||
T62667 | Anticancer agent 51 | ||
Anticancer agent 51 (compound 3d) is a potent anticancer agent (Ki: 731.62 nM) with anticancer activity. anticancer agent 51 has potential for prostate cancer research. | |||
T72502 | Anticancer agent 92 | ||
Anticancer agent 92 is an anticancer agent that is nontoxic against noncancerous cells . | |||
T63599 | Anticancer agent 54 | ||
Anticancer agent 54 is an effective anticancer agent whose anticancer activity depends on DNA embedding and ROS generation. Anticancer agent 54 has an anti-proliferative effect by blocking the cell cycle in G0/G1 phase a... | |||
T63587 | Anticancer agent 45 | ||
Anticancer agent 46 is a potent and selective anticancer agent that induces apoptosis. anticancer agent 46 exhibits cytotoxic effects in cancer cells and shows low toxicity to activated lymphocytes of human blood. | |||
T63982 | Anticancer agent 50 | ||
Anticancer agent 50 (compound 6) is a potent modulator of the ABCB1 efflux pump with cytotoxic and anti-proliferative activity. anticancer agent 50 reduces the expression of cyclin D1 and induces p53 expression. anticanc... | |||
T61902 | Anticancer agent 69 | ||
Anticancer agent 69 (Compound 34) is an effective selective anticancer agent with selective inhibition on human prostate cancer cell line PC3 (IC50=26 nM). Anticancer agent 69 can increase ROS level and down-regulate EGF... | |||
T83091 | Anticancer agent 113 | ||
Anticancer agent 113 possesses anticancer activity [1]. | |||
T74961 | Anticancer agent 84 | ||
Anticancer Agent 84, a cancer research compound, inhibits c-MYC transcription by stabilizing the G-quadruplex (G4) structure, offering potential for cancer investigation [1]. | |||
T63489 | Anticancer agent 77 | ||
Anticancer agent 77 exhibits anticancer effects and can be used extensively in synthetic and medicinal chemistry studies. | |||
T72474 | Anticancer agent 53 | ||
Anticancer agent 53 is a potent compound exhibiting significant in vitro cytotoxicity, inducing apoptosis, and promoting cell cycle arrest in the S/G2/M phases, while demonstrating antitumor activity without apparent tox... |